Carvolix secures up to EUR30 million structured debt facility
Carvolix entered a four-tranche structured-debt agreement with Claret Capital to support commercialisation and industrialisation of its interventional-robotics portfolio.
Evidence notes
- The facility provides up to EUR30 million across four tranches, including an immediate EUR10 million draw.
- A second EUR10 million tranche is linked to FDA approval of the Tavipilot robot; the financing includes convertible bonds and warrants.
- Proceeds are allocated to commercialisation, industrialisation and market-access work for Tavipilot and Kalios.